HIV

;
Biomedical HIV Prevention Summit: Scaling Up PrEP Now by Leveraging Existing Programs

Biomedical HIV Prevention Summit: Scaling Up PrEP Now by Leveraging Existing Programs

Apr 9, 2024

HIV+Hepatitis Policy Institute will convene a panel on Friday, April 19, 2024, at the Biomedical HIV Prevention Summit to examine how PrEP is provided today by entities including community health centers, CBOs, pharmacies, telemedicine platforms, and state health departments. We will examine how this work is financed by leveraging existing programs and systems, as well as current barriers and what can be done to close PrEP access gaps in underserved populations.

read more

North Carolina Blue Cross Blue Shield HIV Drug Tiers

Sep 12, 2023

Carl Schmid discusses NC Blue Cross Blue Shield’s decision to remove HIV drugs from the highest and costliest drug tiers following a discrimination complaint filed by the HIV+Hepatitis Policy Institute and NC AIDS Action Network.

read more
Braidwood v Becerra: Amicus Briefs

Braidwood v Becerra: Amicus Briefs

Sep 8, 2023

Carl Schmid and Kevin Herwig offer updates at USCHA on Braidwood v Becerra, which challenges ACA’s preventive services coverage requirement, and discuss the amicus brief filed by HIV+Hepatitis Policy Institute and supported by 24 HIV and hepatitis organizations and other amici briefs filed by other groups.

read more

Search

Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing Drug Pricing healthcare Hepatitis Hepatitis B Hepatitis C HIV HIV Prevention Insurers Medicaid NAIC PBMs PrEP Prescription Drugs Private Insurance Ryan White Program state Testing transparency Treatment Trump administration

Recent Presentations

Pin It on Pinterest